- Active not recruitingPHASE1
A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone
This study is for adults with head and neck cancer that has spread or returned. It tests if combining new medicines like BI 770371, pembrolizumab, and cetuximab can shrink tumors better than pembrolizumab alone. It aims to see if these combinations help the immune system fight cancer.
For: Head and Neck Squamous Cell CarcinomaUnited States · Australia · Brazil - Active not recruitingPHASE1
A Study in People With Advanced Cancer to Test How Well Different Doses of BI 770371 Alone or in Combination With Ezabenlimab Are Tolerated
This study is for adults with advanced cancer that hasn't responded to other treatments. It's testing new medicines, BI 770371 and ezabenlimab, to see how safe they are and what doses patients can comfortably take, hoping to help the immune system fight cancer.
For: Solid TumorsUnited States · Canada · Japan